Logo image of TMC

TMC THE METALS CO INC (TMC) Stock Fundamental Analysis

NASDAQ:TMC - Nasdaq - CA87261Y1060 - Common Stock - Currency: USD

1.96  -0.26 (-11.71%)

After market: 1.9501 -0.01 (-0.51%)

Fundamental Rating

0

Overall TMC gets a fundamental rating of 0 out of 10. We evaluated TMC against 150 industry peers in the Metals & Mining industry. TMC may be in some trouble as it scores bad on both profitability and health. TMC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

TMC had negative earnings in the past year.
TMC had a negative operating cash flow in the past year.
In the past 5 years TMC always reported negative net income.
In the past 5 years TMC always reported negative operating cash flow.
TMC Yearly Net Income VS EBIT VS OCF VS FCFTMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

TMC has a worse Return On Assets (-184.45%) than 99.30% of its industry peers.
Industry RankSector Rank
ROA -184.45%
ROE N/A
ROIC N/A
ROA(3y)-131.2%
ROA(5y)-101.09%
ROE(3y)-413.33%
ROE(5y)-289.2%
ROIC(3y)N/A
ROIC(5y)N/A
TMC Yearly ROA, ROE, ROICTMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMC Yearly Profit, Operating, Gross MarginsTMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, TMC has more shares outstanding
TMC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TMC Yearly Shares OutstandingTMC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M
TMC Yearly Total Debt VS Total AssetsTMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

TMC has an Altman-Z score of -14.85. This is a bad value and indicates that TMC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TMC (-14.85) is worse than 95.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.85
ROIC/WACCN/A
WACCN/A
TMC Yearly LT Debt VS Equity VS FCFTMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M

2.3 Liquidity

TMC has a Current Ratio of 0.05. This is a bad value and indicates that TMC is not financially healthy enough and could expect problems in meeting its short term obligations.
TMC has a Current ratio of 0.05. This is amonst the worse of the industry: TMC underperforms 99.30% of its industry peers.
A Quick Ratio of 0.05 indicates that TMC may have some problems paying its short term obligations.
TMC's Quick ratio of 0.05 is on the low side compared to the rest of the industry. TMC is outperformed by 99.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
TMC Yearly Current Assets VS Current LiabilitesTMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M

1

3. Growth

3.1 Past

The earnings per share for TMC have decreased strongly by -42.31% in the last year.
EPS 1Y (TTM)-42.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

TMC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.94% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y15.51%
EPS Next 2Y22.67%
EPS Next 3Y14.84%
EPS Next 5Y51.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMC Yearly Revenue VS EstimatesTMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
TMC Yearly EPS VS EstimatesTMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

TMC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TMC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMC Price Earnings VS Forward Price EarningsTMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMC Per share dataTMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.1 -0.2 -0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as TMC's earnings are expected to grow with 14.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.67%
EPS Next 3Y14.84%

0

5. Dividend

5.1 Amount

No dividends for TMC!.
Industry RankSector Rank
Dividend Yield N/A

TMC THE METALS CO INC

NASDAQ:TMC (2/21/2025, 4:37:32 PM)

After market: 1.9501 -0.01 (-0.51%)

1.96

-0.26 (-11.71%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-24 2025-03-24/amc
Inst Owners5.57%
Inst Owner Change77.9%
Ins Owners15.21%
Ins Owner Change-0.28%
Market Cap674.30M
Analysts77.14
Price Target4.06 (107.14%)
Short Float %6.03%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.91%
Min EPS beat(2)-18.81%
Max EPS beat(2)0.99%
EPS beat(4)1
Avg EPS beat(4)-21.03%
Min EPS beat(4)-58.42%
Max EPS beat(4)0.99%
EPS beat(8)4
Avg EPS beat(8)3.09%
EPS beat(12)7
Avg EPS beat(12)6.07%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.85%
PT rev (3m)-4.02%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)13.79%
EPS NY rev (1m)1.14%
EPS NY rev (3m)-26.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS-0.06
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -184.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-131.2%
ROA(5y)-101.09%
ROE(3y)-413.33%
ROE(5y)-289.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 227.11%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -14.85
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)176.01%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y15.51%
EPS Next 2Y22.67%
EPS Next 3Y14.84%
EPS Next 5Y51.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.7%
EBIT Next 3Y20.45%
EBIT Next 5Y101.35%
FCF growth 1Y39.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.75%
OCF growth 3YN/A
OCF growth 5YN/A